TG Therapeutics (TGTX) earnings per share (EPS)

Earnings per share · fiscal 2025
$2.77

TG Therapeutics (TGTX) reported diluted earnings per share of $2.77 in fiscal 2025 (the year ended December 31, 2025). That is 1746.7% higher than the $0.15 of fiscal 2024. Figures as of 17 Nov 2026, 23:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$2.77
Change on fiscal 2024
+1746.7%
Highest on record
$2.77fiscal 2025
Lowest on record
-$2.63fiscal 2021
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

TG Therapeutics earnings per share (EPS), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $2.77 in fiscal 2025 and the lowest -$2.63 in fiscal 2021.

History · 6 fiscal years

Earnings per share by fiscal year

TG Therapeutics earnings per share (EPS), year by year

TG Therapeutics (TGTX) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$2.77 1,746.7% up
2024$0.15 66.7% up
2023$0.09—
2022-$1.46—
2021-$2.63—
2020-$2.42—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of TG Therapeutics and comparable companies
CompanyEarnings per shareFiscal year
Madrigal Pharmaceuticals MDGL-$12.852025
Henry Schein HSIC$3.272025
Oscar Health OSCR-$1.692025
TG Therapeutics TGTX$2.772025
Praxis Precision Medicines PRAX-$13.482025
Twist Bioscience TWST-$1.302025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TGTX

TG Therapeutics, figure by figure

TG Therapeutics (TGTX) overview: price, valuation and scorecardAll health care companies by market value

TG Therapeutics earnings per share (EPS): questions and answers

What is TG Therapeutics's diluted earnings per share?

TG Therapeutics (TGTX) reported diluted earnings per share of $2.77 in fiscal 2025 (the year ended December 31, 2025). That is 1746.7% higher than the $0.15 of fiscal 2024.

What are the highest and lowest diluted earnings per share figures on record for TG Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $2.77 in fiscal 2025 and the lowest -$2.63 in fiscal 2021.

How is TG Therapeutics's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TG Therapeutics (TGTX) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/TGTX/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.